gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

Anterior chamber IOL Phakic 6 in myopia

Meeting Abstract

  • corresponding author P. Rozsival - Department of Ophthalmology, Charles University, Hradec Kralove, Czech Republic
  • A. Feuermannova - Department of Ophthalmology, Charles University, Hradec Kralove, Czech Republic
  • J. Urminsky - Department of Ophthalmology, Charles University, Hradec Kralove, Czech Republic
  • V. Lorencova - Department of Ophthalmology, Charles University, Hradec Kralove, Czech Republic

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogSA.08.04

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/dog2004/04dog351.shtml

Published: September 22, 2004

© 2004 Rozsival et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Objective

To evaluate safety, effectiveness, predictability, and stability of angle-supported phakic intraocular lens (PIOL) implantation for the correction of high myopia.

Setting: Interventional case serie at author's working place.

Methods

67 eyes of 38 patients (12 men, 55 women) we implanted an angle supported PIOL Phakic 6 (29 bilateraly). Mean age was 28.1 years. Follow-up to 2 years. All surgeries were done in parabulbar anaesthesia.

Results

The mean spherical equivalent refraction decreased from -10.12 D to -0.12 D and remained stable. BCVA was 0.86 before and 0.96 after surgery, UCVA was 0.92 after operation. No sight-threatening complications occured through the follow-up period. Non significant pupil ovalization was observed in 5.9% eyes one year and in 32.1% two years after surgery.

Conclusions

AC Phakic 6 IOL can be sucessfully used for correction of high myopia with stable, predictable results.